← Open Payments lookup

NGUYET NGUYEN: Open Payments

NPI 1083143093 · MIDLOTHIAN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,183 in 172 payments from 22 companies in 2025. Trend: 2023 $3,488 · 2024 $3,828 · 2025 $4,183

Food & beverage: $3,957Education: $226
CompanyPaymentsAmount
Paratek Pharmaceuticals, Inc.24$487
Galderma Laboratories, L.P.12$409
UCB, Inc.14$359
SUN PHARMACEUTICAL INDUSTRIES INC.12$343
ABBVIE INC.11$292
Amgen Inc.9$226
Janssen Biotech, Inc.2$225
Arcutis Biotherapeutics, Inc.6$210
E.R. Squibb & Sons, L.L.C.16$195
Ortho Dermatologics, a division of Bausch Health US, LLC8$179

Products named: NUZYRA, NEMLUVIO, Bimzelx, DUPIXENT, OTEZLA, TREMFYA, Winlevi, RINVOQ.

Industry payments across TX — which companies pay providers there.